Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Epidemiological studies of the non-specific effects of vaccines: II--methodological issues in the design and analysis of cohort studies.
Farrington, CP; Firth, MJ; Moulton, LH; Ravn, H; Andersen, PK; EVANS, S; Working Group on Non-specific Effects of Vaccines,;
2009
Tropical medicine & international health, (2009).14 9 10.1111/j.1365-3156.2009.02302.x.
Effect of recurrent invasive pneumococcal disease on serum anti-pneumolysin IgG titres in HIV infected adults.
Etuwewe, OM; Swann, N; Hollingshead, S; Tolmie, H; Zijlstra, EE; Faragher, B; FRENCH, N; Gordon, SB;
2009
Vaccine, (2009).27 29 10.1016/j.vaccine.2009.04.026.
Reduction of meningitis and impact on under-5 pneumonia after introducing the Hib vaccine in the Kingdom of Tonga.
Russell, FM; Fakakovi, T; Paasi, S; Ika, A; MULHOLLAND, EK;
2009
Annals of tropical paediatrics, (2009).29 2 10.1179/146532809X440725.
Prospective surveillance of streptococcal sore throat in a tropical country.
Steer, AC; Jenney, AW J; Kado, J; Good, MF; Batzloff, M; Magor, G; Ritika, R; MULHOLLAND, KE; Carapetis, JR;
2009
The Pediatric infectious disease journal, (2009).28 6 10.1097/INF.0b013e318194b2af.
On the relationship between meningococcal transmission dynamics and disease: remarks on humoral immunity.
Guzzetta, G; Manfredi, P; Gasparini, R; Panatto, D; EDMUNDS, WJ;
2009
Vaccine, (2009).27 25-26 10.1016/j.vaccine.2009.01.092.
Clinical laboratory practices for the detection of rotavirus in England and Wales: can surveillance based on routine laboratory testing data be used to evaluate the impact of vaccination?.
ATCHISON, CJ; Lopman, BA; Harris, CJ; TAM, CC; Iturriza Gómara, M; Gray, JJ;
2009
Euro surveillance, (2009).14 20 10.2807/ese.14.20.19217-en.
A chlamydial type III-secreted effector protein (Tarp) is predominantly recognized by antibodies from humans infected with Chlamydia trachomatis and induces protective immunity against upper genital tract pathologies in mice.
Wang, J; Chen, L; Chen, F; Zhang, X; Zhang, Y; Baseman, J; Perdue, S; Yeh, I-T; Shain, R; HOLLAND, M; BAILEY, R; MABEY, D; Yu, P; Zhong, G;
2009
Vaccine, (2009).27 22 10.1016/j.vaccine.2009.02.095.
Broadening the age restriction for initiating rotavirus vaccination in regions with high rotavirus mortality: benefits of mortality reduction versus risk of fatal intussusception.
Patel, MM; CLARK, AD; Glass, RI; Greenberg, H; Tate, J; Santosham, M; SANDERSON, CF B; Steele, D; Cortese, M; Parashar, UD;
2009
Vaccine, (2009).27 22 10.1016/j.vaccine.2009.03.016.
Timing of children's vaccinations in 45 low-income and middle-income countries: an analysis of survey data.
CLARK, A; SANDERSON, C;
2009
Lancet, (2009).373 9674 10.1016/S0140-6736(09)60317-2.
Japanese encephalitis: defining risk incidence for travelers to endemic countries and vaccine prescribing from the UK and Switzerland.
Hatz, C; Werlein, J; Mutsch, M; Hufnagel, M; BEHRENS, RH;
2009
Journal of travel medicine, (2009).16 3 10.1111/j.1708-8305.2009.00334.x.